Moxifloxacin Tablets Manufacturer & Exporter

Product Overview
Key Features
Therapeutic Uses
Dosage Form Advantages

Genliva Wellness LLP is a leading Moxifloxacin Tablets Manufacturer in India manufacturing broad-spectrum fluoroquinolone antibacterial formulations for respiratory infections, sinusitis, pneumonia, skin infections, typhoid fever, and complicated bacterial disease management therapies.

Moxifloxacin interferes with bacterial DNA gyrase and topoisomerase enzymes responsible for bacterial replication and survival. The medicine demonstrates strong antibacterial activity against respiratory and gram-positive bacterial pathogens and is frequently prescribed in lower respiratory tract infection treatment protocols.

Genliva Wellness LLP supplies WHO GMP antibiotic formulations from Gujarat for pharmaceutical distribution, third party manufacturing, institutional medicine procurement, private labeling services, and export-focused pharmaceutical healthcare markets worldwide.

Moxifloxacin Tablets are formulated for broad-spectrum antibacterial therapy.

Fluoroquinolone oral antibiotic formulation
Frequently utilized in respiratory infection treatment
Activity against gram-positive and gram-negative pathogens
Optimized oral tablet administration profile
Manufactured under WHO GMP quality standards
Intended for outpatient antibacterial therapies

This formulation is prescribed in respiratory and bacterial infection management.

Treatment of pneumonia and sinusitis
Management of typhoid fever conditions
Administered in skin bacterial infection therapies
Utilized in lower respiratory tract infections
Targets susceptible bacterial pathogens
Frequently selected in oral antibacterial protocols

Moxifloxacin Tablets deliver broad-spectrum fluoroquinolone antibacterial therapy for bacterial infections.

Valuable in respiratory infection treatment
Frequently preferred in lower airway bacterial care
Broad antibacterial activity against multiple pathogens
Convenient oral antibacterial therapy option
Useful in typhoid and skin infection management
Maintains strong fluoroquinolone antibacterial performance